Symbiotec Pharmalab Stock: price and insider trades · India
Symbiotec Pharmalab: what insiders have been doing
Symbiotec Pharmalab is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). The last twelve months, up to 10 November 2026, brought 17 filings signed by 15 insiders.
There is no open-market purchase to report; the filings show 16 sales worth €1.1M by 14 insiders. Raman Prasad Verma filed the largest sale, €184k, on 5 October 2026, which represents 0.027% of the company's market value.
Compared with its exchange (1,986 companies, median 4 filings), a count of 17 filings is above the norm. Over the whole record (from 2026), the tally stands at no purchases and 16 sales.
Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+8 other insiders
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,000 shares@ ₹1,174.500.0016% mcap100.0% of flowEquityMarket SaleSEBI:708996db1b9f46d2303a8bf81fe12a2df9362411
- 2,000 shares@ ₹1,185.000.0032% mcap100.0% of flowEquityMarket SaleSEBI:357a741c8365b7e3c673bf381216164b74022784
- 9,200 shares@ ₹1,164.700.014% mcap100.0% of flowEquityMarket SaleSEBI:9137d22eaa639ebb6e7cf7b49da6dbb201903ab3
- 1,000 shares@ ₹1,093.700.0015% mcap15.9% of flowEquityMarket SaleSEBI:e972bff9683880514512a1f86d54053e30c6d3be
- 5,500 shares@ ₹1,175.200.0086% mcap100.0% of flowEquityMarket SaleSEBI:aac71ce3cb16f94b2671cd7137a622a3df019eea
- 1,000 shares@ ₹1,180.000.0016% mcap100.0% of flowEquityMarket SaleSEBI:1d5770c68a88c128c5b789e3e079e400639efa3e
- 7,000 shares@ ₹1,154.000.011% mcap100.0% of flowEquityMarket SaleSEBI:cf77967b280fed84f3f7120e57de6b80e8f6673a
- 12,470 shares@ ₹1,173.600.020% mcap100.0% of flowEquityMarket SaleSEBI:1d42bcc82c1db88005e1e2b850a09e97fd7e3a1a
- 900 shares@ ₹1,049.900.0013% mcap28.4% of flowEquityMarket SaleSEBI:f450bda14128b2d67370a3a55ad52192ccbbd435
- 11,500 shares@ ₹1,168.600.018% mcap100.0% of flowEquityMarket SaleSEBI:fb684fe065fda0f9ecf0b9807f8e489d2a44ed8d
- 2,000 shares@ ₹1,190.000.0032% mcap71.6% of flowEquityMarket SaleSEBI:42c2c4f2c1cf86759bbeeb4bd7cdee0f71dee4d7
- 2,500 shares@ ₹1,172.600.0039% mcap100.0% of flowEquityMarket SaleSEBI:6b2fd2709b3e1c499828bc7dd9952d177c69c26e
- 8,500 shares@ ₹1,183.600.013% mcap100.0% of flowEquityMarket SaleSEBI:ef4996e4aba5361b2a64b8e4b1f13519ebc9c8ee
- 15,000 shares@ ₹1,177.400.024% mcap100.0% of flowEquityMarket SaleSEBI:049e7c75a913b9cf27390b720a5fac205e7e9ccd
- 17,000 shares@ ₹1,168.600.027% mcap100.0% of flowEquityMarket SaleSEBI:c7b557c834eadb74a5a08b14d613af787b0d73ca
- 5,500 shares@ ₹1,054.800.0077% mcap84.1% of flowEquityMarket SaleSEBI:6c9d6fd66151c0b748c447645c8682512a60a5a7
- 2,227,734 shares-CreationSEBI:641abea44ba158006a8b979a5bd88ce9f85a4caa
17 of 17 declarations
About Symbiotec Pharmalab
Symbiotec Pharmalab is a company specializing in the manufacturing of pharmaceutical products. It is listed on the XBOM market.